Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Estrella Immunopharma (ESLA) Earnings Date, Estimates & Call Transcripts

Estrella Immunopharma logo
$1.19 +0.05 (+4.04%)
As of 01:49 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Estrella Immunopharma Earnings Summary

Estrella Immunopharma posted Q1 2026 earnings on May 15, 2026, reporting an EPS of -$0.05, which beat analysts' consensus estimates of -$0.08 by $0.03. With a trailing EPS of -$0.34, Estrella Immunopharma's earnings are expected to grow next year, from ($0.39) to ($0.32) per share.

Q1 2026 Earnings Resources

Latest Q1 2026
Earnings Date
May. 15Estimated
Consensus EPS
(May. 15)
-$0.08
Actual EPS
(May. 15)
-$0.05 Beat By $0.03
Get Estrella Immunopharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Estrella Immunopharma and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ESLA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Estrella Immunopharma Analyst EPS Estimates

Current Year EPS Consensus Estimate
($0.39) EPS
Next Year EPS Consensus Estimate
($0.32) EPS

Estrella Immunopharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/15/2026Q1 2026-$0.0840-$0.05+$0.0340-$0.05--
3/18/2026Q4 2025-$0.18-$0.01+$0.17-$0.01--
11/12/2025Q4 2025-$0.1865-$0.13+$0.0565-$0.13--
9/27/2024Q4 2024--$0.13--$0.13--

Data powered by Fiscal.ai.

Estrella Immunopharma Earnings - Frequently Asked Questions

Estrella Immunopharma (NASDAQ:ESLA) last announced its quarterly earning data on Friday, May 15, 2026. Learn more on ESLA's earnings history.

In the previous quarter, Estrella Immunopharma (NASDAQ:ESLA) reported ($0.05) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.08) by $0.03. Learn more on analysts' earnings estimate vs. ESLA's actual earnings.

Estrella Immunopharma (NASDAQ:ESLA) has a recorded net income of -$13.06 million. ESLA has generated -$0.34 earnings per share over the last four quarters.

Estrella Immunopharma's earnings are expected to grow from ($0.39) per share to ($0.32) per share in the next year.


This page (NASDAQ:ESLA) was last updated on 5/21/2026 by MarketBeat.com Staff.
From Our Partners